ReviewFrontiers in oncology2020

Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments.

Massimo Offidani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.